Published Online
on April 27, 2009

A more recent version of this article appeared on June 1, 2009

This Article Full Text (PDF) All Versions of this Article: 53/6/909    most recent HYPERTENSIONAHA.109.130427v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Wesseling, S. Articles by Joles, J. A. Search for Related Content PubMed PubMed Citation Articles by Wesseling, S. Articles by Joles, J. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Coronary Artery Disease Dietary Supplements Related Collections Nutrition Animal models of human disease Risk Factors Coronary circulation Lipid and lipoprotein metabolism Related Article

Taurine. Red Bull or Red Herring?

Sebastiaan Wesseling; Maarten P. Koeners; and Jaap A. Joles^*

From the Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.

^* To whom correspondence should be addressed. E-mail: j.a.joles{at}umcutrecht.nl.

Related Article:

High Dietary Taurine Reduces Apoptosis and Atherosclerosis in the Left Main Coronary Artery: Association With Reduced CCAAT/Enhancer Binding Protein Homologous Protein and Total Plasma Homocysteine but not Lipidemia

Anthony Zulli, Eza Lau, Bagus P.P. Wijaya, Xin Jin, Komang Sutarga, Grace D. Schwartz, Jonathon Learmont, Peter J. Wookey, Angelo Zinellu, Ciriaco Carru, and David L. Hare
Hypertension 2009 53: 1017-1022. [Abstract] [Full Text] [PDF]